Cardiologist, outcomes researcher, pickleballer, soccer player, retired rower, and forever Buckeye
Kansas City, MO
Joined June 2015
- Tweets303
- Following69
- Followers550
- Likes1.6K
Suzanne Arnold retweeted
In an analysis of 1056 undergoing transcatheter valve intervention for tricuspid regurgitation, health status improvement was maximised in those that achieved a 3-grade reducation in TR severity @djc795 @shannonmdunlay @suzannevarnold ahajrnls.org/4ufx21u
Suzanne Arnold retweeted
Despite concerns that the KCCQ is particularly vulnerable to placebo benefit effects, in a sham-controlled trial it was estimated to be <2 points @djc795 @HFpEF @howard_herrmann @donaldcutlip @tavrkapadia @davidmu41359397 @suzannevarnold @MajaCikes ahajrnls.org/45aAW0J
Can we please stop the practice of clapping in the middle of every LBCT? It makes sense for something like COAPT, with so much effort and surprisingly/strikingly positive results. Meeting a NI endpoint with a wide margin shouldn’t cause eruption in applause. Just clap at the end.
One of the most fun things I did in 2025. I was so excited to be a part of this Case Record of the MGH and the Shared Decision Making Forum. And meeting this patient who lived life to the utmost was a true honor. ❤️ @mghsdm
Case Record of the Massachusetts General Hospital (@MassGeneralNews): A 93-year-old woman was evaluated by her primary care physician because of dyspnea. She had a history of aortic stenosis and atrial fibrillation and flutter. A diagnosis was made. Read the full case details: nej.md/4nnSjSb
ALT Case Records of the Massachusetts General Hospital A 93-Year-Old Woman with Dyspnea and Fatigue Panels A and B: Chest radiographs
Suzanne Arnold retweeted
🚨 New paper out in JACC!
We examined angina trajectories in the ISCHEMIA trial—how patients’ symptoms evolved over 2 years after an initial invasive vs conservative strategy.
jacc.org/doi/10.1016/j.jacc.…
👉I’ll summarize the key findings in this thread.
Suzanne Arnold retweeted
Happening now
Rock Star @suzannevarnold presenting late breaker on TriQol clinical study of health status impact of tricuspid interventions
@crfheart
@MidAmericaHeart
Suzanne Arnold retweeted
I am saddened to learn about President Biden’s diagnosis of what seems to be metastatic prostate cancer. However, let’s please get away with the “fighter” metaphor. It’s harmful. This “fight” metaphor leads to excessive and harmful care. And choosing a treatment that prioritizes quality of life is not being “not a fighter” or giving up. If you want to read more about this, see the links in the next post.
Suzanne Arnold retweeted
Real-world low-risk TAVR outcomes in the USA: 1-year mortality & stroke rates were slightly higher than pivotal trial results from the 3 STS/ACC TVT registry. @djc795 @wfearonmd @tavrkapadia
@arnoldgehrke @VinodThourani @_WayneBatchelor
@TsuyoshiKaneko1 ahajournals.org/doi/full/10.…
Suzanne Arnold retweeted
🚨 We’re hiring!
…told you to wait for it!
Seeking a Director of Cardiovascular Research to lead groundbreaking studies & mentor future clinical scholars.
📍 Kansas City, MO
💡 Leadership, research, & academic impact
🔗 Apply now or share!
@saintlukeskc
@MidAmericaHeart
nam12.safelinks.protection.o…
Suzanne Arnold retweeted
The #JACC Journal Club invites you to a virtual discussion, Wednesday, Feb. 26, at 5:30 pm ET, on the 1-year results of the TRILUMINATE & TRISCEND II pivotal trials
Learn more & register: share.hsforms.com/1uU196vYnS…
#JACCJournals #CathLab @GilbertTangMD @meganfburke @arnoldgehrke
Suzanne Arnold retweeted
For patients with tricuspid regurgitation, the extent of disease appears to influence 1-year mortality following T-TEER, confirm new prospective European registry data. @PhilippLurz @arnoldgehrke
tctmd.com/news/intermediate-…
Suzanne Arnold retweeted
Watch Now! 👉www. opci.live/journal-club/ The latest OPCI Journal Club features @arnoldgehrke on "Quality of Life after Transcatheter Tricuspid Valve Replacement: Results from the TRISCEND II Pivotal Trial." Joined by esteemed panelists @djc795 @CathElectroSurg and Drs. William Chung and Ailia Rizvi. #CardioTwitter
Suzanne Arnold retweeted
The best teams eat tapas together and celebrate #AHA24
🫶🏻🫀
@MidAmericaHeart @saintlukeskc @HealthcareUMKC @arnoldgehrke @MAbdeljawadmd @Dr_BowTie65 @DrIribarne @AndrewJSauer @Nobu0129 @EvOkeefe @AHAMeetings @AHAScience
Suzanne Arnold retweeted
#TCT2024: Drs. @arnoldgehrke, @hahn_rt, @SusheelKodaliMD, @djc795, et al present secondary analyses from the #TRISCENDII pivotal trial with #simpub in #JACC
They find that #TTVR for #vhdTR is assoc w/ sustained health status improvement at 1 yr bit.ly/3Ukv6En
Suzanne Arnold retweeted
🚀 Let's kick off the first late-breaking trials session at #TCT2024 in collaboration with @NEJM!
🔍 EARLY TAVR
🔍 EVOLVED
🔍 TAVR UNLOAD
@PhilGenereuxMD @drnvanmieghem @JaneALeopold @arnoldgehrke @TsuyoshiKaneko1 @LindenfeldJoann @slittlemd #CardioX #CardioResearch
Suzanne Arnold retweeted
Just go with the flow in aortic stenosis (AS)? Get up to date in normal-flow low-gradient AS – definitions, diagnosis, points of error, and management strategies in the US and European guidelines. bit.ly/46CbbWo
#JACCIMG @AhmedElkaryoni @arnoldgehrke
1. Low KCCQ scores are associated with increased risk of HFH and death; improvements in scores reduce that risk.
2. That does NOT mean the KCCQ is a surrogate marker. Or that it is only an important outcome to measure because of this prognostic association.